Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Autologous CD34+ cells transfected with lentiviral vector containing the Wiskott-Aldrich syndrome protein gene

EU orphan designation number: EU/3/12/998   
Active ingredient: Autologous CD34+ cells transfected with lentiviral vector containing the Wiskott-Aldrich syndrome protein gene
Indication: Treatment of Wiskott-Aldrich syndrome
Sponsor: GlaxoSmithKline Trading Services Limited
Currabinny, Carrigaline, County Cork, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
08/06/2012 Orphan designation EMA/OD/014/12 (2012)3842 of 06/06/2012
11/10/2013 Change of name and/or address of sponsor
09/12/2014 Transfer of orphan designation EMA/OD/014/12/T/01 (2014)9542 of 05/12/2014